# Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study

> **NCT00371098** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Institute of Cardiology, Warsaw, Poland** · enrollment: 658 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **BIOLOGICAL:** Influenza vaccination: Influvac (SolvayPharma)
- **BIOLOGICAL:** placebo influenza vaccine

## Key facts

- **NCT ID:** NCT00371098
- **Lead sponsor:** National Institute of Cardiology, Warsaw, Poland
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 658 (ACTUAL)
- **Last updated:** 2007-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00371098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00371098, "Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00371098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*